(Q38178191)

30 August 2017

title

Asthma and cystic fibrosis: a tangled web. (English)

1 reference

30 August 2017

0 references

1 reference

Brian D Kent

1

1 reference

30 August 2017

Stephen J Lane

2

1 reference

30 August 2017

Edwin J van Beek

3

1 reference

30 August 2017

Jonathan D Dodd

4

1 reference

30 August 2017

Richard W Costello

5

1 reference

30 August 2017

Harm A W M Tiddens

6

1 reference

30 August 2017

publication date

13 January 2014

1 reference

30 August 2017

published in

Pediatric Pulmonology

1 reference

30 August 2017

volume

49

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

205-213

1 reference

"CF asthma": what is it and what do we do about it?

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Cluster analysis and clinical asthma phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Airway hyperreactivity in cystic fibrosis. Clinical correlates and possible effects on the course of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Airways reactivity in patients with CF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Bronchial constriction and inhaled colistin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Repeat exercise normalizes the gas-exchange impairment induced by a previous exercise bout in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Exhaled nitric oxide in pulmonary diseases: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Clinical applications of induced sputum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Airway inflammation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Association between pulmonary function and sputum biomarkers in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Infection, inflammation, and lung function decline in infants with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Remodeling of the airway epithelium in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Active albuterol or placebo, sham acupuncture, or no intervention in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Computed tomographic imaging of the airways: relationship to structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

The role of inhaled corticosteroids in the management of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Corticosteroids and skeletal muscle function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Anti-inflammatory effects of montelukast in mild cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

A pilot study of zafirlukast as an anti-inflammatory agent in the treatment of adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Theophylline again? Reasons for believing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Effect of Theophylline on Lung Function Tests, Sleep Quality, and Nighttime SaO2in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

21 January 2018

Omalizumab for asthma

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.22934

Inhaled bronchodilators for cystic fibrosis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003428.PUB2

Identifiers

DOI

10.1002/PPUL.22934

1 reference

30 August 2017

1 reference